Energetic technical and procurement leader promoting over 17 years of experience in life cycle strategy design & deployment, supply chain, manufacturing, sourcing and negotiations; with superior record of accomplishment. Experienced team leader who worked with line and cross functional teams to deliver corporate goals by establishing effective relationships with an agile mindset.
Strong business acumen with proficient contract negotiation skills.
Strategic thinking individual experienced in translating internal & external factors into an actionable plan.
Hired, trained, managed, and mentored team members.
- Commercial Launch of key Roche blockbuster (>$2B) globally (incl. China)
- Preparation of Products for Light touch lifecycle management
- Global strategy deployment at products level
- Change management
- Lead of the breast cancer POD (4 Product strategy leaders) to support appropriate development of PT strategy
- Lead of sustainability initiatives
- Lead for key company initiatives (eg CDMO strategy, individualized Therapy industrialization)
- Technical Program lead for products from diverse technologies: Antibody drug conjugates, Antibodies, bispecifics, cancer vaccine
- Management of biggest accounts which serve Roche Pharma Technical
- Responsibility of over 400M annual spend in 2019
- Key contributor towards saving targets in direct pharma procurement (>100M/ year)
- Site manager for products from different technologies: Antibody drug conjugates, Antibodies, small molecule
- Multiple project related recognition awards
- Budget responsibility of over 10 million Euros
- Technology Transfer of development program to commercial facility in 6 Months
- Green Belt certification: Technology Transfer acceleration
Graduated with honors, Dean List
Graduated with honors
co-authored several publications in the space of genetic engineering and bioprocess manufacturing technological advancement. Presented research findings at international conferences
#1. Implementation of new bioreactor & information technology into existing facilities; presented at BioTech 2010: Single-Use Technology in Biopharmaceutical Manufacturing; 7-8th June 2010; Wädenswil.
# 2. Etablierung einer auf Einwegfermentern basierenden Entwicklungs- und Transferplattform für Fermentationsprozesse tierischer Zellkulturen; presented at the Annual Meeting of the Committee for Bioprocess Engineering of the German Society of Engineers 2010 in Nürnberg.
# 3. Disposable Systems as Platform Technology for R&D and Clinical Supply, BioProduction 2009, October 27-28, Barcelona.
#1. In Search of a Reliable Scale-Down Model, Genetics Engineering and Biotechnology News. June 2010.
# 2. Use of technology in biologics manufacture, American Pharmaceutical Review. Nov-Dec 2006.
#3. The crystal structure of carnitine palmitoyl transferase 2 and implications for diabetes treatment. Arne C Rufer et al. Structure 14, 713-723, April 2006.
#1. Implementation of new bioreactor & information technology into existing facilities; presented at BioTech 2010: Single-Use Technology in Biopharmaceutical Manufacturing; 7-8th June 2010; Wädenswil.
# 2. Etablierung einer auf Einwegfermentern basierenden Entwicklungs- und Transferplattform für Fermentationsprozesse tierischer Zellkulturen; presented at the Annual Meeting of the Committee for Bioprocess Engineering of the German Society of Engineers 2010 in Nürnberg.
# 3. Disposable Systems as Platform Technology for R&D and Clinical Supply, BioProduction 2009, October 27-28, Barcelona.
#1. In Search of a Reliable Scale-Down Model, Genetics Engineering and Biotechnology News. June 2010.
# 2. Use of technology in biologics manufacture, American Pharmaceutical Review. Nov-Dec 2006.
Abstracts at international conferences:
#1. Implementation of new bioreactor & information technology into existing facilities; presented at BioTech 2010: Single-Use Technology in Biopharmaceutical Manufacturing; 7-8th June 2010; Wädenswil.
# 2. Etablierung einer auf Einwegfermentern basierenden Entwicklungs- und Transferplattform für Fermentationsprozesse tierischer Zellkulturen; presented at the Annual Meeting of the Committee for Bioprocess Engineering of the German Society of Engineers 2010 in Nürnberg.
# 3. Disposable Systems as Platform Technology for R&D and Clinical Supply, BioProduction 2009, October 27-28, Barcelona.
Publications
#1. In Search of a Reliable Scale-Down Model, Genetics Engineering and Biotechnology News. June 2010.
# 2. Use of technology in biologics manufacture, American Pharmaceutical Review. Nov-Dec 2006.
#3. The crystal structure of carnitine palmitoyl transferase 2 and implications for diabetes treatment. Arne C Rufer et al. Structure 14, 713-723, April 2006.